Hi San Fran and Koo, I agree that there should be a lot of questions answered leading up to and at the AGM. As we all know the delayed AGM is very unusual and as many of us have touched on the delay in conjunction with whatever the opportunity that Don has been following up on and Ken L's share purchase, together create an interesting set of circumstances. Throw in the London presentation and there is a lot to chew on so to speak. Personally I am hoping that perhaps there will be a strong presence from AstraZeneca there as we know that RVX would be a good fit for them for a few reasons.